共 65 条
[1]
Seib CD(2019)Evolving understanding of the epidemiology of thyroid cancer Endocrinol Metab Clin North Am 48 23-35
[2]
Sosa JA(1994)Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 418-428
[3]
Mazzaferri EL(2016)2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer Thyroid 26 1-133
[4]
Jhiang SM(2017)Differentiated thyroid cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy Eur J Nucl Med Mol Imaging 44 926-934
[5]
Haugen BR(2018)Association of radioactive iodine administration after reoperation with outcomes among patients with recurrent or persistent papillary thyroid cancer JAMA Surg 153 1098-1104
[6]
Alexander EK(2011)Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation J Clin Endocrinol Metab 96 3695-3700
[7]
Bible KC(2020)Role of adjuvant therapy with radioactive iodine in patients with elevated serum thyroglobulin after neck reoperation due to recurrent papillary thyroid cancer: a monoinstitutional comparative study Endocrine 68 144-150
[8]
Piccardo A(2019)Re-treatment with adjuvant radioactive iodine does not improve recurrence-free survival of patients with differentiated thyroid cancer Front Endocrinol (Lausanne) 10 671-817
[9]
Puntoni M(2014)Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma Nucl Med Commun 35 808-1959
[10]
Bottoni G(2008)Guidelines for radioiodine therapy of differentiated thyroid cancer Eur J Nucl Med Mol Imaging 35 1941-788